Sporos BioDiscovery

Sporos Bio is developing a novel and well differentiated TEAD1/4 inhibitor. Pre-clinical efficacy and safety data suggests a best-in-class agent. Potent efficacy in a broad range of cancer cells lines beyond mesothelioma and NF2 mutations.
Loading